General Information of This Drug (ID: DMKSI2I)

Drug Name
Fosbretabulin   DMKSI2I
Synonyms Zybrestat (TN)
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Everolimus + Fosbretabulin DCNRSEY Everolimus Neuroendocrine Tumors [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02279602) Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03014297) Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression